Jamie L. Reynoso is CEO at CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV). They have made 6 open-market trades across 1 company since 2025, most recently 2026-10-07.
CIK 0001839066
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CLOV | 2,792,690 | $12.5M |
Shares reported on the most recent Form 4, priced at the 2026-10-07 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CLOV | SELL · 10b5-1 | 2026-10-07 | 2026-10-07 | $4.63 | $9K | — | — | — |
| CLOV | SELL | 2026-10-05 | 2026-10-05 | $4.42 | $39K | -0.1% | — | — |
| CLOV | SELL · 10b5-1 | 2026-09-17 | 2026-09-18 | $4.56 | $9K | -5.0% | — | — |
| CLOV | SELL | 2026-09-15 | 2026-09-15 | $4.78 | $44K | -5.4% | -1.4% | — |
| CLOV | SELL · 10b5-1 | 2026-07-17 | 2026-07-17 | $4.53 | $22K | -8.4% | -7.4% | +1.4% |
| CLOV | SELL | 2026-07-15 | 2026-07-16 | $4.67 | $61K | -0.2% | -1.4% | +10.1% |
| CLOV | SELL · 10b5-1 | 2026-07-08 | 2026-07-09 | $4.68 | $11K | +2.6% | -2.4% | -2.7% |
| CLOV | SELL | 2026-07-06 | 2026-07-06 | $5.26 | $33K | -13.1% | -18.5% | -7.4% |
| CLOV | SELL · 10b5-1 | 2026-06-17 | 2026-06-18 | $4.78 | $11K | +7.0% | -11.1% | -10.0% |
| CLOV | SELL | 2026-06-15 | 2026-06-16 | $4.61 | $29K | +8.8% | -10.0% | +4.1% |
| CLOV | SELL · 10b5-1 | 2026-06-11 | 2026-06-11 | $4.91 | $36K | +7.4% | -5.8% | -10.5% |
| CLOV | SELL · 10b5-1 | 2026-03-18 | 2026-03-18 | $1.91 | $11K | -7.5% | +18.3% | +166.1% |
| CLOV | SELL | 2026-01-20 | 2026-01-20 | $2.58 | $12K | -13.8% | -19.6% | -13.8% |
| CLOV | SELL · 10b5-1 | 2026-01-07 | 2026-01-07 | $2.53 | $5K | +3.2% | -15.1% | -24.3% |
| CLOV | SELL · 10b5-1 | 2025-12-18 | 2025-12-18 | $2.61 | $13K | -10.0% | -0.8% | -28.0% |
| CLOV | SELL · 10b5-1 | 2025-11-04 | 2025-11-05 | $3.58 | $218K | -21.4% | -13.7% | -28.1% |
| CLOV | SELL · 10b5-1 | 2025-10-17 | 2025-10-21 | $2.69 | $44K | +10.0% | -32.7% | -19.3% |
| CLOV | SELL · 10b5-1 | 2025-10-07 | 2025-10-07 | $2.65 | $5K | +0.4% | -3.3% | -4.1% |
| CLOV | SELL · 10b5-1 | 2025-09-17 | 2025-09-19 | $3.09 | $15K | -13.5% | -3.6% | -14.9% |
| CLOV | SELL · 10b5-1 | 2025-08-04 | 2025-08-06 | $2.89 | $20K | +14.0% | +20.1% | +53.7% |
| CLOV | SELL · 10b5-1 | 2025-07-03 | 2025-07-08 | $2.59 | $108K | -5.8% | -29.2% | -16.0% |
| CLOV | SELL · 10b5-1 | 2025-06-17 | 2025-06-18 | $2.86 | $58K | -8.9% | -2.6% | +3.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.